Ultragenyx Pharmaceutical Inc (RARE)

Jun 18, 2025

Exploring the Road Ahead: X-linked Hypophosphatemia Market - openPR.com

Jun 18, 2025

Jun 16, 2025

(RARE) Long Term Investment Analysis - news.stocktradersdaily.com

Jun 16, 2025

Jun 14, 2025

Ultragenyx’s SWOT analysis: rare disease biotech stock faces pivotal year By Investing.com - Investing.com Canada

Jun 14, 2025

Jun 14, 2025

Ultragenyx’s SWOT analysis: rare disease biotech stock faces pivotal year - Investing.com Australia

Jun 14, 2025

Jun 13, 2025

FDA approves Ultragenyx's Mepsevii in mucopolysaccharidosis type VII enzyme disorder - FirstWord Pharma

Jun 13, 2025

Jun 10, 2025

Transcript : Ultragenyx Pharmaceutical Inc. Presents at Goldman Sachs 46th Annual Global Healthcare Conference 2025, Jun-10-2025 10 - MarketScreener

Jun 10, 2025

Jun 09, 2025

Ultragenyx (RARE) Q1 2025 Performance Shows Resilience - GuruFocus

Jun 09, 2025

Jun 05, 2025

Ultragenyx reports 28% rise in Q1 revenue from year ago - The Press Democrat

Jun 05, 2025

Jun 05, 2025

Ultragenyx (RARE) Up 9.6% Since Last Earnings Report: Can It Continue? - Yahoo Finance

Jun 05, 2025

Jun 04, 2025

Mucopolysaccharidosis III Pipeline 2025: Groundbreaking - openPR.com

Jun 04, 2025

Jun 04, 2025

How the (RARE) price action is used to our Advantage - news.stocktradersdaily.com

Jun 04, 2025

Jun 03, 2025

Ultragenyx to Participate at Goldman Sachs 46th Annual Global He - GuruFocus

Jun 03, 2025

Jun 03, 2025

Ultragenyx to Participate at Goldman Sachs 46th Annual Global Healthcare Conference | RARE Stock News - GuruFocus

Jun 03, 2025

Jun 03, 2025

Ultragenyx to Participate at Goldman Sachs 46th Annual Global Healthcare Conference - GlobeNewswire

Jun 03, 2025

Jun 03, 2025

Ultragenyx CEO Reveals Latest Rare Disease Breakthroughs at Goldman Sachs Healthcare Conference - Stock Titan

Jun 03, 2025

May 29, 2025

Adeno-Associated Virus (AAV) Vectors in Gene Therapy Pipeline - openPR.com

May 29, 2025

May 29, 2025

William Blair Initiates Coverage of Ultragenyx Pharmaceutical (BMV:RARE) with Outperform Recommendation - Nasdaq

May 29, 2025

May 29, 2025

Ultragenyx Pharmaceutical (NASDAQ:RARE) Coverage Initiated by Analysts at William Blair - Defense World

May 29, 2025

May 28, 2025

William Blair Initiates Coverage of Ultragenyx Pharmaceutical (LSE:0LIF) with Outperform Recommendation - Nasdaq

May 28, 2025

May 28, 2025

William Blair Initiates Coverage of Ultragenyx Pharmaceutical (RARE) with Outperform Recommendation - MSN

May 28, 2025

May 28, 2025

William Blair sets Ultragenyx stock at Outperform with $65 target By Investing.com - Investing.com Australia

May 28, 2025

May 28, 2025

What 4 Analyst Ratings Have To Say About Ultragenyx Pharmaceutical - Benzinga

May 28, 2025

May 28, 2025

Analyst Bullish On Ultragenyx, Poised For Growth With Six Drug Approvals Expected By 2028 - Benzinga

May 28, 2025

May 28, 2025

Ultragenyx Pharmaceutical (RARE) Receives New Coverage with 'Out - GuruFocus

May 28, 2025

May 28, 2025

Ultragenyx Pharmaceutical (RARE) Receives New Coverage with 'Outperform' Rating | RARE Stock News - GuruFocus

May 28, 2025

May 28, 2025

William Blair Initiates Ultragenyx Pharmaceutical at Outperform - marketscreener.com

May 28, 2025

May 28, 2025

William Blair sets Ultragenyx stock at Outperform with $65 target - Investing.com

May 28, 2025

May 28, 2025

Ultragenyx (RARE) Gains Outperform Rating with $65 Target | RARE Stock News - GuruFocus

May 28, 2025

May 26, 2025

Sanfilippo syndrome Pipeline 2025: Groundbreaking Clinical - openPR.com

May 26, 2025

May 25, 2025

Ultragenyx’s SWOT analysis: rare disease biotech stock poised for growth By Investing.com - Investing.com Nigeria

May 25, 2025

May 25, 2025

Ultragenyx’s SWOT analysis: rare disease biotech stock poised for growth - Investing.com

May 25, 2025

May 21, 2025

CDKL5 Deficiency Disorder Market Expected to Experience Major - openPR.com

May 21, 2025

May 21, 2025

Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times

May 21, 2025

May 20, 2025

Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 56 - GuruFocus

May 20, 2025

May 20, 2025

Ultragenyx Grants $4.5M in Stock Awards: 20 New Hires Receive Retention Packages - Stock Titan

May 20, 2025

May 20, 2025

Ultragenyx Pharmaceutical Approves Key Proposals at Annual Meeting - MSN

May 20, 2025

May 14, 2025

Ultragenyx Underscores Continued Commitment to Rare Disease Inno - GuruFocus

May 14, 2025

May 14, 2025

Ultragenyx Underscores Continued Commitment to Rare Disease Innovation with 2024 Impact Report - GlobeNewswire

May 14, 2025

May 14, 2025

Ultragenyx Underscores Continued Commitment to Rare Disease Innovation with 2024 Impact Report | RARE Stock News - GuruFocus

May 14, 2025

May 14, 2025

(RARE) Technical Pivots with Risk Controls - news.stocktradersdaily.com

May 14, 2025

May 13, 2025

Transcript : Ultragenyx Pharmaceutical Inc. Presents at BofA Securities 2025 Healthcare Conference, May-13-2025 08 - marketscreener.com

May 13, 2025

May 12, 2025

Glycogen Storage Disease Treatment Market Size in 7MM - openPR.com

May 12, 2025